Your browser is no longer supported. Please, upgrade your browser.
Settings
AMAG AMAG Pharmaceuticals, Inc. daily Stock Chart
AMAG [NASD]
AMAG Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-10.88 Insider Own2.30% Shs Outstand34.10M Perf Week3.21%
Market Cap274.17M Forward P/E39.95 EPS next Y0.19 Insider Trans25.85% Shs Float33.68M Perf Month-7.55%
Income-368.90M PEG- EPS next Q-0.19 Inst Own- Short Float37.18% Perf Quarter-0.52%
Sales320.60M P/S0.86 EPS this Y-178.40% Inst Trans-4.11% Short Ratio19.63 Perf Half Y-27.26%
Book/sh7.73 P/B1.00 EPS next Y1500.00% ROA-41.70% Target Price8.81 Perf Year-17.36%
Cash/sh3.51 P/C2.20 EPS next 5Y- ROE-96.40% 52W Range4.41 - 13.53 Perf YTD-36.65%
Dividend- P/FCF- EPS past 5Y-35.40% ROI-79.10% 52W High-43.02% Beta0.95
Dividend %- Quick Ratio1.40 Sales past 5Y21.40% Gross Margin64.70% 52W Low74.83% ATR0.66
Employees440 Current Ratio1.50 Sales Q/Q-9.40% Oper. Margin- RSI (14)51.29 Volatility8.70% 8.18%
OptionableYes Debt/Eq0.00 EPS Q/Q79.70% Profit Margin- Rel Volume0.87 Prev Close8.00
ShortableYes LT Debt/Eq1.07 EarningsMay 11 BMO Payout- Avg Volume637.87K Price7.71
Recom3.00 SMA20-1.38% SMA506.78% SMA200-20.74% Volume552,906 Change-3.62%
Oct-30-19Downgrade Piper Jaffray Neutral → Underweight $9 → $6
Aug-01-19Initiated H.C. Wainwright Buy $16
Jun-11-19Initiated Barclays Overweight $19
Mar-20-19Initiated SunTrust Hold
Dec-14-18Reiterated B. Riley FBR Buy $29 → $20.50
Nov-06-18Downgrade JP Morgan Neutral → Underweight
Jun-15-18Downgrade Janney Buy → Neutral
May-21-18Resumed Leerink Partners Mkt Perform
Mar-14-18Reiterated B. Riley FBR, Inc. Neutral $16 → $23
Feb-15-18Upgrade Janney Neutral → Buy
Dec-07-17Initiated B. Riley FBR, Inc. Neutral $16
Oct-23-17Initiated Piper Jaffray Neutral $18
Sep-08-17Initiated Morgan Stanley Overweight $26
Jan-11-17Downgrade Needham Buy → Hold
Jan-10-17Downgrade Leerink Partners Outperform → Mkt Perform
Jan-09-17Downgrade Raymond James Mkt Perform → Underperform
Oct-27-16Initiated Needham Buy $40
May-09-16Reiterated Deutsche Bank Hold $42 → $35
May-04-16Downgrade Raymond James Outperform → Mkt Perform
Jan-21-16Initiated Barclays Equal Weight $32
May-27-20 08:00AM  AMAG Pharmaceuticals to Participate in Jefferies Virtual Global Healthcare Conference GlobeNewswire +5.99%
May-21-20 05:00PM  AMAG Pharmaceuticals Completes Sale of its Rights to Intrarosa® to Millicent Pharma for up to $125 Million GlobeNewswire
May-12-20 12:26PM  AMAG Pharmaceuticals (AMAG) Reports Q1 Loss, Beats on Revenues Zacks
May-11-20 12:00PM  AMAG Pharmaceuticals Inc (AMAG) Q1 2020 Earnings Call Transcript Motley Fool -10.78%
09:45AM  AMAG Pharmaceuticals (AMAG) Reports Q1 Loss, Tops Revenue Estimates Zacks
07:32AM  AMAG Pharmaceuticals: Q1 Earnings Insights Benzinga
07:00AM  AMAG Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire
May-06-20 06:51AM  Should You Buy This Stock That Makes "Viagra for Women"? Motley Fool
May-05-20 06:13AM  Does The AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Share Price Fall With The Market? Simply Wall St.
Apr-28-20 12:33PM  AMAG Pharmaceuticals (AMAG) Earnings Expected to Grow: What to Know Ahead of Q1 Release Zacks -5.20%
07:00AM  AMAG Pharmaceuticals Appoints Scott Myers as President and Chief Executive Officer GlobeNewswire
Apr-27-20 04:30PM  AMAG Pharmaceuticals to Host First Quarter 2020 Financial Results Conference Call and Webcast on Monday, May 11, 2020 GlobeNewswire +7.45%
Apr-16-20 08:00AM  AMAG Pharmaceuticals Provides COVID-19 Company Update GlobeNewswire
Apr-03-20 11:30AM  AMAG Pharmaceuticals (AMAG) Down 21.5% Since Last Earnings Report: Can It Rebound? Zacks
Apr-02-20 01:23PM  LLY, OXM, AMAG, MIST and CPIX as Zacks Bull and Bear of the Day Zacks
Mar-25-20 12:00PM  AMAG Pharmaceuticals (AMAG) Moves to Buy: Rationale Behind the Upgrade Zacks +17.63%
Mar-13-20 03:59AM  Edited Transcript of AMAG earnings conference call or presentation 4-Mar-20 1:00pm GMT Thomson Reuters StreetEvents
Mar-09-20 09:49AM  AMAG Sees High Feraheme Sales, To Sell Women Healthcare Drugs Zacks -5.99%
Mar-05-20 08:21AM  AMAG Q4 Loss Wider Than Expected, Revenues Beat Estimates Zacks
Mar-04-20 08:35AM  AMAG Pharmaceuticals (AMAG) Reports Q4 Loss, Tops Revenue Estimates Zacks
07:00AM  AMAG Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update GlobeNewswire
06:58AM  AMAG Pharmaceuticals Announces Changes to Medical Development Organization GlobeNewswire
Mar-01-20 08:31AM  Have Insiders Been Buying AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Shares? Simply Wall St.
Feb-28-20 08:00AM  AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call and Webcast on Wednesday, March 4, 2020 at 8:00 a.m. ET GlobeNewswire
Feb-26-20 08:46AM  Is a Surprise Coming for AMAG This Earnings Season? Zacks
Feb-19-20 08:53AM  Should You Buy AMAG Pharmaceuticals (AMAG) Ahead of Earnings? Zacks
Feb-14-20 04:34PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG GlobeNewswire
08:00AM  AMAG Pharmaceuticals to Participate in Upcoming Investor Conferences GlobeNewswire
Feb-10-20 05:40PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG ACCESSWIRE
Feb-03-20 03:05PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AMAG Pharmaceuticals, Inc.  AMAG GlobeNewswire
Jan-30-20 12:31PM  AMAG Pharmaceuticals (AMAG) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release Zacks -6.25%
Jan-27-20 02:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG ACCESSWIRE
09:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG GlobeNewswire
Jan-24-20 06:12PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG PR Newswire -17.69%
Jan-21-20 06:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG GlobeNewswire
Jan-14-20 11:05PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG ACCESSWIRE +7.78%
12:00PM  AMAG Pharmaceuticals (AMAG) Upgraded to Buy: Here's Why Zacks
Jan-10-20 06:08PM  AMAG to Sell Women Healthcare Drugs, CEO Resigns, Stock Down Zacks -6.38%
09:59AM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. (AMAG) ACCESSWIRE
Jan-09-20 05:43PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG GlobeNewswire
10:21AM  Amag stock tumbles on CEO departure, divestiture plans MarketWatch
09:55AM  Waltham's Amag Pharma replacing CEO, cutting two products American City Business Journals
07:00AM  AMAG Pharmaceuticals Announces Leadership Transition, Results of Strategic Review to Unlock Shareholder Value and Financial Update GlobeNewswire
Jan-03-20 08:00AM  AMAG Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-18-19 08:00AM  AMAG Pharmaceuticals Awards Four Grants to Support Preterm Birth and Preeclampsia Research GlobeNewswire
Dec-13-19 11:12AM  Hedge Funds Are Souring On AMAG Pharmaceuticals, Inc. (AMAG) Insider Monkey
Dec-06-19 08:00AM  12 Biotech Stocks Primed For A Short Squeeze Benzinga
Dec-02-19 08:20AM  Those Who Purchased AMAG Pharmaceuticals (NASDAQ:AMAG) Shares Five Years Ago Have A 74% Loss To Show For It Simply Wall St.
Dec-01-19 09:30AM  Why Is AMAG Pharmaceuticals (AMAG) Up 9.7% Since Last Earnings Report? Zacks
Nov-26-19 09:19AM  Is the Options Market Predicting a Spike in AMAG Pharmaceuticals (AMAG) Stock? Zacks
Nov-19-19 04:54PM  Teva, Bausch Could Be Next to File for Bankruptcy GuruFocus.com
Nov-16-19 08:18AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG ACCESSWIRE
Nov-13-19 02:14PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG GlobeNewswire +5.21%
08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Nov-07-19 05:44PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG GlobeNewswire
11:44AM  Hedge Funds Are Still Bullish On AMAG Pharmaceuticals (AMAG) Insider Monkey
Nov-06-19 06:18AM  AMAG Sees Hammer Chart Pattern: Time to Buy? Zacks
Nov-05-19 03:35AM  Edited Transcript of AMAG earnings conference call or presentation 1-Nov-19 12:00pm GMT Thomson Reuters StreetEvents
Nov-04-19 11:18AM  AMAG Q3 Loss Wider Than Expected, Revenues Lag Estimates Zacks -5.84%
Nov-01-19 12:25PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG GlobeNewswire
09:15AM  AMAG Pharmaceuticals (AMAG) Reports Q3 Loss, Lags Revenue Estimates Zacks
07:00AM  AMAG Pharmaceuticals Announces Third Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Oct-31-19 11:36AM  The Zacks Analyst Blog Highlights: Alexion, Amgen, Gilead and AMAG Zacks -6.23%
10:55AM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. (AMAG) ACCESSWIRE
Oct-30-19 04:23PM  Biotech Dives After Panel Votes To Pull Its Drug Following Failed Test Investor's Business Daily -22.36%
10:56AM  Biotech Stock Roundup: Q3 Earnings Beat at ALXN & AMGN, Pipeline Updates & More Zacks
10:15AM  What's in Store for GW Pharmaceuticals (GWPH) in Q3 Earnings? Zacks
09:20AM  AMAG Pharmaceuticals Falls 25% After FDA Recommends Removing Makena From The Market Benzinga
Oct-29-19 09:40PM  AMAG Reports on FDA Advisory Committee Meeting for Makena® (Hydroxyprogesterone Caproate Injection) GlobeNewswire
05:05PM  FDA committee votes to pull labor-halting drug from market American City Business Journals
10:29AM  AMAG Pharmaceuticals, Inc. (AMAG) Shares March Higher, Can It Continue? Zacks
10:25AM  Is a Beat in Store for Amarin (AMRN) This Earnings Season? Zacks
07:03AM  AMAG Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee Meeting to Discuss the Results of the Makena PROLONG Trial GlobeNewswire
Oct-28-19 04:21PM  This Biotech Stock Popped But Could The FDA Pull Its Key Drug? Investor's Business Daily +8.73%
06:04AM  Proxy fights reach 'frightening' level in life sciences, other industries, top attorney says American City Business Journals
Oct-27-19 12:56PM  The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings Benzinga
Oct-25-19 10:30AM  AMAG Pharmaceuticals (AMAG) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks +13.83%
10:19AM  AMAG Pharmaceuticals Announces the Publication of the PROLONG Trial Evaluating 17-OHPC in the American Journal of Perinatology GlobeNewswire
Oct-24-19 08:00AM  AMAG Pharmaceuticals to Host Third Quarter 2019 Financial Results Conference Call and Webcast on Friday, November 1, 2019 at 8:00 a.m. ET GlobeNewswire -9.27%
Oct-11-19 08:00AM  AMAG Pharmaceuticals Announces the Publication of the Phase 3 Vyleesi (Bremelanotide Injection) Data in Obstetrics & Gynecology GlobeNewswire
Oct-08-19 08:45AM  UPDATE 2-Amag settles with activist Caligan, adds two board directors Reuters
08:14AM  Amag appoints activist investor Caligan's nominees to board Reuters
08:00AM  AMAG Pharmaceuticals Announces Settlement Agreement with Caligan Partners LP GlobeNewswire
Sep-28-19 09:05AM  Here's Why AMAG Pharmaceuticals (NASDAQ:AMAG) Can Afford Some Debt Simply Wall St.
Sep-26-19 08:00AM  Caligan Partners Issues Letter to AMAG Shareholders Business Wire -5.42%
Sep-25-19 08:00AM  AMAG Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-23-19 08:00AM  AMAG Files Definitive Consent Revocation Statement and Sends Letter to Shareholders GlobeNewswire
Sep-20-19 08:44AM  UPDATE 2-Camber Capital to discuss Amag's board composition with shareholders Reuters +8.54%
08:20AM  Camber Capital says Amag Pharma's shares undervalued, seeks changes Reuters
Sep-16-19 08:00AM  Caligan Partners Launches Consent Solicitation Process and Sends Letter to AMAG Shareholders Business Wire
Sep-12-19 08:00AM  AMAG Sends Letter to Shareholders GlobeNewswire
Sep-06-19 09:31AM  Why Is AMAG Pharmaceuticals (AMAG) Up 27.3% Since Last Earnings Report? Zacks
Sep-05-19 06:24AM  Activist investor pushes for ex-Goop CEO, others to join board of Waltham drugmaker Amag American City Business Journals
Sep-04-19 05:56PM  AMAG Urges Stockholders to Take No Action on Caligan Partners Consent Solicitation Materials GlobeNewswire +8.19%
09:45AM  Activist Investor Seek Four Board Seats at Amag Pharmaceuticals Bloomberg
Aug-30-19 09:29PM  Edited Transcript of AMAG earnings conference call or presentation 7-Aug-19 12:00pm GMT Thomson Reuters StreetEvents
Aug-27-19 08:00AM  AMAG Pharmaceuticals Announces Commercial Availability of Vyleesi (Bremelanotide Injection) GlobeNewswire
Aug-20-19 08:00AM  AMAG Pharmaceuticals Announces Grant of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Aug-16-19 10:42AM  Palatin's (PTN) to Report Q4 Earnings: What's in the Cards? Zacks
06:20AM  Gene therapies to test FDA's approach to regulating drugs after launch, experts say American City Business Journals
AMAG Pharmaceuticals, Inc., a pharmaceutical company, develops, manufactures, and commercializes therapeutics for maternal and women's health, and anemia management in the United States. The company markets Feraheme (ferumoxytol), an intravenous iron replacement therapeutic agent for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron, as well as patients who have chronic kidney disease; Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women pregnant with a single baby who have a history of singleton spontaneous preterm birth; Intrarosa(prasterone) vaginal insert steroid for the treatment of dyspareunia due to menopause; and Vyleesi (bremelanotide), an auto-injector device for the treatment of hypoactive sexual desire disorder in pre-menopausal women. Its product candidates also include AMAG-423 (ovine), an antibody fragment, which is in Phase 2b/3a trial for the treatment of severe preeclampsia in pregnant women; and Ciraparantag, an anticoagulant reversal agent that is in planned Phase 2b trial for the treatment of novel oral anticoagulants or low molecular weight heparin. The company sells Feraheme to authorized wholesalers and specialty distributors. The company has license agreements with Endoceutics, Inc., Palatin Technologies, Inc., Velo Bio, LLC, Prasco, LLC, Perosphere Pharmaceuticals Inc., and Antares Pharma, Inc. AMAG Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ARMISTICE CAPITAL, LLC10% OwnerMar 16Buy4.8724,000116,880348,000Mar 18 04:52 PM
ARMISTICE CAPITAL, LLC10% OwnerFeb 25Buy8.2936,000298,440324,000Feb 27 05:27 PM
ARMISTICE CAPITAL, LLC10% OwnerJan 27Buy9.418,00075,280288,000Jan 28 04:48 PM
ARMISTICE CAPITAL, LLC10% OwnerJan 27Buy9.438,00075,4404,120,000Jan 28 04:48 PM
ARMISTICE CAPITAL, LLC10% OwnerJan 24Buy9.7240,000388,800280,000Jan 28 04:48 PM
ARMISTICE CAPITAL, LLC10% OwnerJan 24Buy9.5834,000325,7204,112,000Jan 28 04:48 PM
ARMISTICE CAPITAL, LLC10% OwnerJan 10Buy11.6418,000209,5204,078,000Jan 13 05:47 PM
ARMISTICE CAPITAL, LLC10% OwnerJan 09Buy12.3312,466153,7064,060,000Jan 13 05:47 PM
ARMISTICE CAPITAL, LLC10% OwnerJan 09Sale12.4312,466154,9524,047,534Jan 13 05:47 PM
Camber Capital Management LP10% OwnerAug 09Buy8.9730,000268,9964,390,000Aug 09 03:41 PM
ARMISTICE CAPITAL, LLC10% OwnerAug 07Buy7.4340,000297,200240,000Aug 09 05:05 PM
ARMISTICE CAPITAL, LLC10% OwnerAug 07Buy7.32260,0001,903,2004,060,000Aug 09 05:05 PM
Camber Capital Management LP10% OwnerAug 07Buy7.78355,0002,760,7964,360,000Aug 09 03:41 PM
ARMISTICE CAPITAL, LLC10% OwnerJun 27Buy9.4720,000189,400200,000Jun 27 06:29 PM
ARMISTICE CAPITAL, LLC10% OwnerJun 27Buy9.5244,000418,8803,800,000Jun 27 06:29 PM
ARMISTICE CAPITAL, LLC10% OwnerJun 26Buy9.13120,0001,095,6003,756,000Jun 27 06:29 PM
ARMISTICE CAPITAL, LLC10% OwnerJun 25Buy8.8655,000487,050180,000Jun 27 06:29 PM
ARMISTICE CAPITAL, LLC10% OwnerJun 25Buy8.59259,0162,224,9473,636,000Jun 27 06:29 PM